Rhea-AI Summary
Prevail Therapeutics (Nasdaq: PRVL) announced that CEO Asa Abeliovich will speak at the Bank of America Global Research Virtual Health Care Conference on May 12, 2020, at 11:40 a.m. ET. The chat will focus on their innovative AAV-based gene therapies aimed at neurodegenerative diseases.
A live webcast of the event will be available on the company’s website and archived for 90 days. Prevail is developing therapies for Parkinson’s disease with GBA1 mutations, frontotemporal dementia with GRN mutations, and other synucleinopathies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.37%
Tags
-
Rhea-AI Summary
Summary not available.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.52%
Tags